Related Experiment Videos
Variability of DNA analysis by image cytometry. Bladder Tumor Marker Network
J E Reeder1, C Cox, L L Wheeless
1University of Rochester, New York 14642, USA. jreeder@acuvx2.pathology.rochester.edu
Cytometry
|June 1, 1997
Summary
This study evaluated DNA analysis variability in bladder tumors using CAS 200 instruments. Specimen differences are the primary source of variability, especially with systematic sampling, highlighting the need for careful documentation.
Area of Science:
- Oncology
- Biomedical Engineering
- Cytometry
Background:
- DNA analysis of bladder tumors is crucial for diagnosis and treatment.
- Variability in DNA ploidy analysis can impact clinical decisions.
- Standardization of cytometric methods is essential for reliable results.
Purpose of the Study:
- To assess the sources of variability in DNA analysis of bladder tumor specimens.
- To compare variability between systematic and selective cell sampling methods.
- To identify factors influencing the reliability of DNA index (DI) and hyperdiploid fraction (HDF) measurements.
Main Methods:
- Two laboratories utilized CAS 200 instruments for DNA analysis.
- Formalin-fixed, paraffin-embedded bladder tumor specimens were processed.
- Systematic and selective sampling methods were employed to measure cell nuclei.
Main Results:
- Specimen differences accounted for 92% of variability in HDF with systematic sampling.
- Selective sampling reduced specimen-dependent variability to 67%, increasing other factors.
- Laboratory and error contributed approximately 10% to overall variability.
Conclusions:
- Specimen variability is the dominant factor in HDF measurements, reflecting biological differences.
- Selective sampling increases sensitivity but requires careful documentation of criteria.
- Standardized sampling protocols are critical for controlling variability in DNA analysis of bladder tumors.